Tinostamustine | Interleukin Related interleukin-related.com

Product Name :
Tinostamustine

Search keywords :
YY1

drugId :
null

Target Vo:
Histone deacetylase 2

Target Vo Short Name :
HDAC2

Moa_Name:
Histone deacetylase 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Mundipharma Edo Gmbh

Active Company_Name :
Hangzhou Minsheng Pharmaceutical Co Ltd

Active Indication_Name:
Lymphoma, Follicular

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
p21 Rabbit mAb Protocol
Frexalimab supplier
GSK3 beta Antibody (YA397): GSK3 beta Antibody (YA397) is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to GSK3 beta. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts